These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Buspirone augmentation of fluoxetine in a depressed child with obsessive-compulsive disorder. Alessi N, Bos T. Am J Psychiatry; 1991 Nov; 148(11):1605-6. PubMed ID: 1928487 [No Abstract] [Full Text] [Related]
5. Buspirone in obsessive-compulsive disorder. Maruno CA, Hart LL. Ann Pharmacother; 1992 Oct; 26(10):1248-51. PubMed ID: 1421651 [No Abstract] [Full Text] [Related]
7. Buspirone and fluoxetine in the treatment of OCD. Judd F, Ellen S, Norman T. Aust N Z J Psychiatry; 1992 Dec; 26(4):684-6. PubMed ID: 1476539 [No Abstract] [Full Text] [Related]
8. An open trial of buspirone in obsessive-compulsive disorder. Jenike MA, Baer L. Am J Psychiatry; 1988 Oct; 145(10):1285-6. PubMed ID: 3048120 [Abstract] [Full Text] [Related]
10. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder. McDougle CJ, Goodman WK, Leckman JF, Holzer JC, Barr LC, McCance-Katz E, Heninger GR, Price LH. Am J Psychiatry; 1993 Apr; 150(4):647-9. PubMed ID: 8465885 [Abstract] [Full Text] [Related]
11. The addition of buspirone to SSRI in the treatment of adolescent obsessive-compulsive disorder. A study of six cases. Thomsen PH, Mikkelsen HU. Eur Child Adolesc Psychiatry; 1999 Jun; 8(2):143-8. PubMed ID: 10435463 [No Abstract] [Full Text] [Related]
12. Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial. Liebowitz MR, Hollander E, Schneier F, Campeas R, Hatterer J, Papp L, Fairbanks J, Sandberg D, Davies S, Stein M. J Clin Psychopharmacol; 1989 Dec; 9(6):423-7. PubMed ID: 2687337 [Abstract] [Full Text] [Related]
13. Neuroendocrine responses to single doses of buspirone in obsessive-compulsive disorder. Norman TR, Apostolopoulos M, Burrows GD, Judd FK. Int Clin Psychopharmacol; 1994 Dec; 9(2):89-94. PubMed ID: 8056999 [Abstract] [Full Text] [Related]
14. Serotonin syndrome from fluvoxamine and buspirone. Baetz M, Malcolm D. Can J Psychiatry; 1995 Sep; 40(7):428-9. PubMed ID: 8548727 [No Abstract] [Full Text] [Related]
15. An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder. Fontaine R, Chouinard G. J Clin Psychopharmacol; 1986 Apr; 6(2):98-101. PubMed ID: 3517083 [Abstract] [Full Text] [Related]
16. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder. Pato MT, Pigott TA, Hill JL, Grover GN, Bernstein S, Murphy DL. Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696 [Abstract] [Full Text] [Related]
17. Paradoxical reaction to buspirone augmentation of fluoxetine. Tanquary J, Masand P. J Clin Psychopharmacol; 1990 Oct; 10(5):377. PubMed ID: 2258456 [No Abstract] [Full Text] [Related]
18. Open trial of fluoxetine in obsessive-compulsive disorder. Jenike MA, Buttolph L, Baer L, Ricciardi J, Holland A. Am J Psychiatry; 1989 Jul; 146(7):909-11. PubMed ID: 2787123 [Abstract] [Full Text] [Related]
19. Efficacy of long-term fluoxetine treatment of obsessive-compulsive disorder. Frenkel A, Rosenthal J, Nezu A, Winston A. Mt Sinai J Med; 1990 Nov; 57(6):348-52. PubMed ID: 2079952 [Abstract] [Full Text] [Related]